PT. Penta Valent Tbk (IDX:PEVE)
Indonesia · Delayed Price · Currency is IDR 440.00
0.00 (0.00%)
Last updated: Aug 14, 2025
PT. Penta Valent Tbk Revenue
PT. Penta Valent Tbk had revenue of 845.65B IDR in the quarter ending June 30, 2025, with 18.98% growth. This brings the company's revenue in the last twelve months to 3.27T, up 17.81% year-over-year. In the year 2024, PT. Penta Valent Tbk had annual revenue of 3.01T with 21.25% growth.
Revenue (ttm)
3,273.22B
Revenue Growth
+17.81%
P/S Ratio
0.24
Revenue / Employee
2.21B
Employees
971
Market Cap
787.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3,012.74B | 528.07B | 21.25% |
| Dec 31, 2023 | 2,484.68B | 337.34B | 15.71% |
| Dec 31, 2022 | 2,147.33B | 359.31B | 20.10% |
| Dec 31, 2021 | 1,788.03B | 407.33B | 29.50% |
| Dec 31, 2020 | 1,380.70B | -50.49B | -3.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 3,202.64B |
| PT Kalbe Farma Tbk. | 33.38T |
| PT Mitra Keluarga Karyasehat Tbk | 4,985.33B |
| PT Siloam International Hospitals Tbk | 12.22T |
| PT Medikaloka Hermina Tbk | 6,761.48B |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 3,851.30B |
| PT Tempo Scan Pacific Tbk | 13.48T |
| PT Metro Healthcare Indonesia Tbk | 311.61B |